Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections

INTRODUCTION: Dalbavancin is approved for acute bacterial skin and skin structure infections (ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive infections. Importantly, dalbavancin’s real benefits may be in treating complicated infections in vulnerable patient p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bork, Jacqueline T., Heil, Emily L., Berry, Shanna, Lopes, Eurides, Davé, Rohini, Gilliam, Bruce L., Amoroso, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522607/
https://www.ncbi.nlm.nih.gov/pubmed/31054088
http://dx.doi.org/10.1007/s40121-019-0247-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522607/
https://www.ncbi.nlm.nih.gov/pubmed/31054088
http://dx.doi.org/10.1007/s40121-019-0247-0

Ejemplares similares